A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2004
10/07/2004	US20040198716 Cysteine protease inhimbitors
10/07/2004	US20040198698 Nitrate ester-cyclodextrin complexes
10/07/2004	US20040198692 C-pyrazole A2A receptor agonists
10/07/2004	US20040198674 Compositions for preventing hormone induced adverse effects
10/07/2004	US20040198668 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents
10/07/2004	US20040198662 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders
10/07/2004	US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon
10/07/2004	US20040198656 Methods of screening molecules that are used to prevent cardiovascular diseases
10/07/2004	US20040198654 Glucagon-like peptide-1analogs
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040198641 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders
10/07/2004	US20040198633 Fungicide against Candida, Entomocorticum, Stereum, Phellinus, Peniophora, Xilaria, Rosellinia, Multiclavula, Hericium, and/or Tricholoma; flucytosine, miconazole,ketoconazole, fluconazole, amphotericin B extracted from culture of Streptomyces and/or nystatin
10/07/2004	US20040197902 Transgenic mammalian endothelial progenitor cells for use in the treatment of vision defects; gene therapy and neovascularization
10/07/2004	US20040197860 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/07/2004	US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004	US20040197429 Selective COX-2 inhibition from plant extracts
10/07/2004	US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen
10/07/2004	US20040197404 Extended release oral dosage form
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses
10/07/2004	US20040197265 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions
10/07/2004	DE10312969A1 Benzofuro-1,4-diazepin-2-on-Derivate Benzofuro-1,4-diazepin-2-one derivatives
10/07/2004	CA2816489A1 Perivascular mesenchymal precursor cells
10/07/2004	CA2520422A1 Compositions for treating angina
10/07/2004	CA2520397A1 Activation specific inhibitors of nf-kb and method of treating inflammatory processes in cardio-vascular diseases
10/07/2004	CA2520390A1 Perivascular mesenchymal precursor cell induced blood vessel formation
10/07/2004	CA2520273A1 Perivascular mesenchymal precursor cells
10/07/2004	CA2520147A1 Compound having affinity with calcified tissue
10/07/2004	CA2519987A1 Benzofuro-1,4-diazepin-2-one derivatives
10/07/2004	CA2519681A1 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
10/06/2004	EP1464673A2 Polyanhydrides with biologically active degradation products
10/06/2004	EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp
10/06/2004	EP1464639A1 Succinic acid ester of probucol for the inhibition of the expression of VCAM-1
10/06/2004	EP1464339A1 Cell migration inhibitor
10/06/2004	EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
10/06/2004	EP1463823A2 Methods of increasing endogenous erythropoietin (epo)
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463754A2 Cystine-knot fold protein
10/06/2004	EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004	EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463563A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
10/06/2004	EP1463541A2 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
10/06/2004	EP1463531A1 Methods for inhibiting ocular processes
10/06/2004	EP1463514A2 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances
10/06/2004	EP1463510A2 Administration of vasopeptidase inhibitors to reduce pulse pressure
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463503A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1463487A1 Liposomal delivery of vitamin e based compounds
10/06/2004	EP1463440A2 Prevention of flap necrosis in plastic surgery
10/06/2004	EP1463438A2 Endomural therapy
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1379262B1 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
10/06/2004	EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/06/2004	EP1263300B1 Improvements in or relating to solubilisation of flavonols
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use
10/06/2004	EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP1094797B1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels
10/06/2004	EP1032424B9 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
10/06/2004	EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004	EP1018878B1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
10/06/2004	EP0975340B1 Therapeutic inhibitor of vascular smooth muscle cells
10/06/2004	EP0869810B1 Cyclosporin-containing soft capsule preparations
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535271A Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/06/2004	CN1535265A Novel crystal of arylethenesulfonamide derivative and process for producing the same
10/06/2004	CN1535261A New phenylalkyloxy-phenyl derivatives
10/06/2004	CN1535163A Delivery system for nucleic acids
10/06/2004	CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries
10/06/2004	CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
10/06/2004	CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004	CN1535148A Imidazole derivatives for moudlating sodium channels
10/06/2004	CN1535146A 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors
10/06/2004	CN1535145A Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors
10/06/2004	CN1535139A Atorvastatin hemi-calcium form VII
10/06/2004	CN1534091A Plant vinegar health care oral liquid and its making method
10/06/2004	CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease
10/06/2004	CN1534025A Preparation method of benzimidazole derivative or its salt
10/06/2004	CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004	CN1534016A Calcium acceptor active compound
10/06/2004	CN1534010A Water soluble extract of red sage root and its preeparation method and use
10/06/2004	CN1533804A Medicine for treating inner, external haemorrhoids and its processing method
10/06/2004	CN1533791A Chinese medicine scented tea
10/06/2004	CN1169837C Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom
10/06/2004	CN1169825C Process for extracting triterpenic acid from gleditschia, and medical use and chinese medicine of triterpenic acid
10/06/2004	CN1169808C 'Beta'-carboline compound
10/06/2004	CN1169791C Novel acetamide derivatives and protease inhibitors
10/06/2004	CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases

1 ... 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 ... 1595